Rankings
▼
Calendar
ONC Q2 2025 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena
ONC
BeOne Medicines Ltd.
$33B
Q2 2025 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$1.3B
+41.6% YoY
Gross Profit
$1.2B
87.5% margin
Operating Income
$88M
6.7% margin
Net Income
$94M
7.2% margin
EPS (Diluted)
$0.84
QoQ Revenue Growth
+17.7%
Cash Flow
Operating Cash Flow
$264M
Free Cash Flow
$200M
Stock-Based Comp.
$151M
Balance Sheet
Total Assets
$6.3B
Total Liabilities
$2.5B
Stockholders' Equity
$3.8B
Cash & Equivalents
$2.8B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.3B
$929M
+41.6%
Gross Profit
$1.2B
$791M
+45.5%
Operating Income
$88M
-$107M
+182.0%
Net Income
$94M
-$120M
+178.3%
Revenue Segments
Product
$1.7B
99%
Collaboration
$13M
1%
Geographic Segments
UNITED STATES
$694M
53%
CHINA
$433M
33%
Europe
$152M
12%
All Other Countries Except China And United States Of America
$36M
3%
← FY 2025
All Quarters
Q3 2025 →